Anti-RPRD1B monoclonal antibody

Pre-made anti-RPRD1B monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to RPRD1B/RPRD1B products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2907-Ab-1/ GM-Tg-hg-IP2907-Ab-2Anti-Human RPRD1B monoclonal antibodyHuman
GM-Tg-rg-IP2907-Ab-1/ GM-Tg-rg-IP2907-Ab-2Anti-Rat RPRD1B monoclonal antibodyRat
GM-Tg-mg-IP2907-Ab-1/ GM-Tg-mg-IP2907-Ab-2Anti-Mouse RPRD1B monoclonal antibodyMouse
GM-Tg-cynog-IP2907-Ab-1/ GM-Tg-cynog-IP2907-Ab-2Anti-Cynomolgus/ Rhesus macaque RPRD1B monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2907-Ab-1/ GM-Tg-felg-IP2907-Ab-2Anti-Feline RPRD1B monoclonal antibodyFeline
GM-Tg-cang-IP2907-Ab-1/ GM-Tg-cang-IP2907-Ab-2Anti-Canine RPRD1B monoclonal antibodyCanine
GM-Tg-bovg-IP2907-Ab-1/ GM-Tg-bovg-IP2907-Ab-2Anti-Bovine RPRD1B monoclonal antibodyBovine
GM-Tg-equg-IP2907-Ab-1/ GM-Tg-equg-IP2907-Ab-2Anti-Equine RPRD1B monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2907-Ab-1/ GM-Tg-hg-IP2907-Ab-2; GM-Tg-rg-IP2907-Ab-1/ GM-Tg-rg-IP2907-Ab-2;
GM-Tg-mg-IP2907-Ab-1/ GM-Tg-mg-IP2907-Ab-2; GM-Tg-cynog-IP2907-Ab-1/ GM-Tg-cynog-IP2907-Ab-2;
GM-Tg-felg-IP2907-Ab-1/ GM-Tg-felg-IP2907-Ab-2; GM-Tg-cang-IP2907-Ab-1/ GM-Tg-cang-IP2907-Ab-2;
GM-Tg-bovg-IP2907-Ab-1/ GM-Tg-bovg-IP2907-Ab-2; GM-Tg-equg-IP2907-Ab-1/ GM-Tg-equg-IP2907-Ab-2
Products NameAnti-RPRD1B monoclonal antibody
Formatmab
Target NameRPRD1B
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-RPRD1B monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2907-Ag-1Recombinant multi-species RPR1B/ RPRD1B/ C20orf77 protein
    ORF Viral VectorvGMLP004874human RPRD1B Lentivirus particle
    ORF Viral VectorpGMLP004874human RPRD1B Lentivirus plasmid


    Target information

    Target IDGM-IP2907
    Target NameRPRD1B
    Gene ID58490,70470,311591,700056,485866,101098943,529700,100055539
    Gene Symbol and Synonyms2610304G08Rik,2810446G03Rik,C13H20ORF77,C20orf77,CREPT,dJ1057B20.2,K-H,Kub5-Hera,NET60,RGD1304782,RPRD1B
    Uniprot AccessionQ9NQG5
    Uniprot Entry NameRPR1B_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000101413
    Target ClassificationN/A

    The target: RPRD1B, gene name: RPRD1B, also named as C20orf77, CREPT, K-H, Kub5-Hera, NET60, dJ1057B20.2. Enables RNA polymerase II complex binding activity and identical protein binding activity. Involved in positive regulation of cell population proliferation; regulation of cell cycle process; and regulation of transcription by RNA polymerase II. Located in nucleoplasm. Part of RNA polymerase II, holoenzyme. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.